OnKure Therapeutics (OKUR) vs ProMIS Neurosciences (PMN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
OnKure Therapeutics (OKUR) has outperformed ProMIS Neurosciences (PMN) over the past year, losing 21.4% versus a loss of 32.4%. Over five years, PMN leads with a -95.9% price change compared with -96.4% for OKUR. OnKure Therapeutics is the larger company by market cap ($93.1 million vs $82.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OKUR | PMN |
|---|---|---|
| Share price | $2.30 | $9.15 |
| Market cap | $93.14M | $82.05M |
| 1-day change | -2.13% | +0.33% |
| YTD return | -18.97% | +33.53% |
| 1-year return | -21.40% | -32.44% |
| 5-year return | -96.35% | -95.95% |
| EPS (TTM) | $-3.04 | $-11.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.38 | $27.40 |
| 52-week low | $2.13 | $6.27 |
| Distance from 52-week high | -57.25% | -66.61% |
| Average volume | 211.44K | 84.01K |
| Shares outstanding | 40.50M | 8.97M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OKUR has outperformed PMN by 11.0 percentage points over the past year.
OKUR vs PMN FAQ
Which is bigger, OnKure Therapeutics or ProMIS Neurosciences?
OnKure Therapeutics (OKUR) is larger, with a market capitalization of $93.14M compared with $82.05M for ProMIS Neurosciences (PMN).
Which stock has performed better over the past year, OKUR or PMN?
OKUR returned -21.40% over the past 12 months, compared with -32.44% for PMN (price return, excluding dividends). Past performance does not predict future results.
Are OnKure Therapeutics and ProMIS Neurosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.